• Building AI for the Drug Discovery Learning Problem

    Bio-IT World | At the Bio-IT World Conference and Expo Europe yesterday, Richard Law, chief business officer for Exscientia, kicked off the event with an AI reality check. The term AI barely means anything anymore, he said, but he’s not the least bit soured on the possibility. We just need to shift our expectations.

    Oct 19, 2022

  • Illumina Unveils New Fleet Of Sequencing Instruments

    Bio-IT World | The recent Illumina Genomics Forum occasioned the launch of several game-changing products, including the first FDA-regulated and CE-marked in vitro diagnostic high-throughput sequencer (NovaSeq 6000 Dx) and the company’s most powerful sequencer to date (NovaSeq X series) that can run 20,000 whole human genomes a year on a single instrument.

    Oct 18, 2022

  • With More Oncology Data at Our Fingertips, Interpretation Tools Are Key

    Bio-IT World | Oncology has been a shining example of the promise of precision medicine, and the tremendous gains to be made in human health when patients can be prescribed the right drug at the right time. But oncology has also shown the challenge of precision medicine: data interpretation. With each new source of data, the difficulty of making sense of the aggregated information only increases.

    Oct 14, 2022

  • Interactive Microbial Atlas Outlines Associations Between the Gut Microbiome and Plasma Metabolites

    Bio-IT World | A team of Swedish researchers from Uppsala and Lund Universities created the first large-scale microbial atlas, linking gut microbiota to specific metabolites and their potential health impact on humans.

    Oct 13, 2022